[Skip to Content]
[Skip to Content Landing]
Article
April 1986

Hemorrhage vs Rethrombosis After Thrombolysis for Acute Myocardial Infarction

Author Affiliations

From the Division of Cardiovascular Diseases, William Beaumont Hospital, Royal Oak, Mich (Drs Timmis, Ramos, Gordon, Gangadharan, Westveer, Hauser, and Stewart); and the Department of Surgery, School of Medicine, Wayne State University, Detroit (Dr Mammen).

Arch Intern Med. 1986;146(4):667-672. doi:10.1001/archinte.1986.00360160069009
Abstract

• To determine whether or not the timing of heparin infusion affects either bleeding or reocclusion following intracoronary streptokinase for acute myocardial infarction, heparin was infused immediately after streptokinase in 89 patients and was delayed for 12 hours in the subsequent 93. Bleeding occurred in 22 immediate-heparin patients and was major in five (one fatal); there were 14 hemorrhages in the delayed-heparin group, all minor. At discharge, reocclusions were observed in 18% (12/68) of immediate-heparin patients, and 11% (3/27) of the latter. Bioassayed fibrinogen levels displayed sustained depression regardless of bleeding for 20 hours after streptokinase; however, defibrinogenation measured by immunoassay was much less striking. This suggests that high levels of fibrinogen degradation products spuriously affect the bioassay of fibrinogen. We conclude that bleeding is related to the anticoagulant effects of fibrinogen degradation products interacting with heparin, and may be largely independent of hypofibrinogenemia. Delaying heparin for 12 hours may decrease the risk of bleeding while little affecting the risk of reocclusion.

(Arch Intern Med 1986;146:667-672)

References
1.
Timmis GC, Gangadharan V, Ramos RG, et al:  Hemorrhage and the products of fibrinogen digestion after intracoronary administration of streptokinase.  Circulation 1984;69:1146-1152.Crossref
2.
Tennant SN, Dixon J, Venable TC, et al:  Intracoronary thrombolysis in patients with acute myocardial infarction: Comparison of the efficacy of urokinase with streptokinase.  Circulation 1984;69:756-760.Crossref
3.
Timmis GC, Gangadharan V, Mammen E, et al:  Hemorrhage versus rethrombosis after coronary thrombolysis: The effect of delaying heparin, abstracted.  J Am Coll Cardiol 1984;3:600.
4.
Timmis GC, Gangadharan V, Hauser AM, et al:  Intracoronary streptokinase in clinical practice.  Am Heart J 1982;104:925-938.Crossref
5.
Timmis GC, Gangadharan V, Hauser AM, et al:  Intracoronary thrombolysis in a non-university hospital.  Vase Med 1983;1:96-116.
6.
Cowley MJ, Hastillo A, Vetrovec GW, et al:  Effects of intracoronary streptokinase in acute myocardial infarction.  Am Heart J 1981;102:1149-1158.Crossref
7.
Clauss VA:  Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens.  Acta Haematol 1957;17:237-246.Crossref
8.
Fahey JL, McKelvey EM:  Quantitative determination of serum immunoglobulin in antibody-agar plates.  J Immunol 1965;94:84-90.
9.
Duckert F, Müller G, Nyman D, et al:  Treatment of deep vein thrombosis with streptokinase.  Br Med J 1975;1:479-481.Crossref
10.
Cowley MJ, Hastillo A, Vetrovec GW, et al:  Fibrinolytic effects of intracoronary streptokinase administration in patients with acute myocardial infarction and coronary insufficiency.  Circulation 1983;67:1031-1038.Crossref
11.
Matthews MW, Kuhn JL, Smalling RW:  Incidence of bleeding complications associated with intracoronary streptokinase therapy for acute myocardial infarction, abstracted.  Circulation 1983;68( (suppl 3) ):III-292.
12.
Becher H, Schröder C, Mathey D, et al:  Coronary artery bypass grafting within 24 hours after intracoronary thrombolysis-risk of bleeding, abstracted.  Circulation 1983;68( (suppl 3) ):III-115.
13.
Feinstein AR:  Clinical Biostatistics . St Louis, CV Mosby Co, 1977, pp 321-324.
14.
Rothbard RL, Fitzpatrick PG, Francis CW, et al:  Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase, abstracted.  Circulation 1985;71:562-570.Crossref
15.
Schwartz JL, Ferguson DW, Brayden GP, et al:  Hematologic parameters in patients who fail intracoronary streptokinase thrombolysis, abstracted.  Circulation 1983;68( (suppl 3) ):III-325.
16.
Gangadharan V, Ramos R, Hauser AM, et al:  Consequences of reocclusion after successful intracoronary thrombolysis, abstracted.  Circulation 1983;68( (suppl 3) ):III-209.
×